Kyntra Bio, Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
40.441 USD
−47.58 M USD
29.62 M USD
3.75 M
About Kyntra Bio, Inc.
Sector
Industry
CEO
Thane Wettig
Website
Headquarters
San Francisco
Founded
1993
Identifiers
3
ISIN US31572Q8814
Kyntra Bio, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0IL8 is 7.700 USD — it has increased by 3.35% in the past 24 hours. Watch Kyntra Bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange Kyntra Bio, Inc. stocks are traded under the ticker 0IL8.
0IL8 stock has risen by 1.99% compared to the previous week, the month change is a −15.20% fall, over the last year Kyntra Bio, Inc. has showed a −33.66% decrease.
We've gathered analysts' opinions on Kyntra Bio, Inc. future price: according to them, 0IL8 price has a max estimate of 43.00 USD and a min estimate of 43.00 USD. Watch 0IL8 chart and read a more detailed Kyntra Bio, Inc. stock forecast: see what analysts think of Kyntra Bio, Inc. and suggest that you do with its stocks.
0IL8 reached its all-time high on Jul 9, 2018 with the price of 1,697.500 USD, and its all-time low was 5.970 USD and was reached on Apr 9, 2025. View more price dynamics on 0IL8 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0IL8 stock is 3.32% volatile and has beta coefficient of 0.82. Track Kyntra Bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is Kyntra Bio, Inc. there?
Today Kyntra Bio, Inc. has the market capitalization of 30.14 M, it has decreased by −7.88% over the last week.
Yes, you can track Kyntra Bio, Inc. financials in yearly and quarterly reports right on TradingView.
Kyntra Bio, Inc. is going to release the next earnings report on Mar 2, 2026. Keep track of upcoming events with our Earnings Calendar.
0IL8 earnings for the last quarter are 49.61 USD per share, whereas the estimation was −4.01 USD resulting in a 1.34 K% surprise. The estimated earnings for the next quarter are −3.89 USD per share. See more details about Kyntra Bio, Inc. earnings.
Kyntra Bio, Inc. revenue for the last quarter amounts to 1.08 M USD, despite the estimated figure of 2.43 M USD. In the next quarter, revenue is expected to reach 1.42 M USD.
0IL8 net income for the last quarter is 148.47 M USD, while the quarter before that showed −7.60 M USD of net income which accounts for 2.05 K% change. Track more Kyntra Bio, Inc. financial stats to get the full picture.
No, 0IL8 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 15, 2026, the company has 225 employees. See our rating of the largest employees — is Kyntra Bio, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Kyntra Bio, Inc. EBITDA is −36.97 M USD, and current EBITDA margin is −433.04%. See more stats in Kyntra Bio, Inc. financial statements.
Like other stocks, 0IL8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kyntra Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Kyntra Bio, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Kyntra Bio, Inc. stock shows the sell signal. See more of Kyntra Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.